When was GreenLight Biosciences founded?

GreenLight Biosciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Where is GreenLight Biosciences located?

GreenLight Biosciences is headquartered in Lexington, United States. It is registered at Medford, Massachusetts.

Who is the current CEO of GreenLight Biosciences?

Andrey Zarur of GreenLight Biosciences. They have also founded 1 company.

How many employees does GreenLight Biosciences have?

As of Aug 31, 2026, the latest employee count at GreenLight Biosciences is 175.

Is GreenLight Biosciences a funded company?

GreenLight Biosciences is a funded company, having raised a total of $225M across 13 funding rounds to date. The company's 1st funding round was a $31.9K Grant (prize money) round, raised on Dec 21, 2009.

When was the latest funding round of GreenLight Biosciences?

GreenLight Biosciences' latest funding was a $25M Post IPO round on Apr 07, 2025, with participation from 1 investor.

What is the annual revenue of GreenLight Biosciences?

Annual revenue of GreenLight Biosciences is between $1M and $10M as on Dec 31, 2022

Is GreenLight Biosciences a Genomics company?

The primary sector of GreenLight Biosciences is Genomics.

Where does GreenLight Biosciences rank among its competitors?

GreenLight Biosciences ranks 1st amongst 79 active competitors, of which 6 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Shanghai Yirui Biotechnology Co, which secured $14.7M in Jul, 2026.

Who are the top competitors of GreenLight Biosciences?

GreenLight Biosciences' top competitors include Veritas Genetics, ARCpoint Labs and Dynacare. Among them, Shanghai Yirui Biotechnology Co secured the most recent funding round in July, 2026.

GreenLight Biosciences - 2026 Company Profile, Team, Funding, Competitors & Financials

GreenLight Biosciences is a public company based in Lexington (United States), founded in 2008 by Andrey Zarur. It operates as a Developer of a platform for RNA-based products for life science industry. GreenLight Biosciences has raised $225M in funding from investors like Baird Capital, Khosla Ventures and Kodiak Venture Partners. The company has 79 active competitors, including 6 funded and 5 that have exited. Its top competitors include companies like Veritas Genetics, ARCpoint Labs and Dynacare.

Sectors and market segments that GreenLight Biosciences operate in

GreenLight Biosciences serves in the Life Sciences market segments.The primary business model of GreenLight Biosciences is:

Life Sciences > Genomics > ***** **** > ***** ******

Company Details

Developer of a platform for RNA-based products for the life science industry. It offer platform that is used for vaccine development, antibody therapies, pandemic preparation, crop management, plant protection, support the health of bees and other pollinators

Website: greenlightbiosciences.com
Social
Email ID: *****@greenlightbiosciences.com
Phone Number: +1 **********
Registered Address: Medford, Massachusetts

Key Metrics

Founded Year

2008

Location

Lexington, United States

Stage

Public

Total Funding

$225M in 13 rounds

Latest Funding Round

Post IPO, Apr 07, 2025, $25M

Investors

Baird Capital & 37 more

Ranked

1^st among 79 active competitors

Annual Revenue

$1M - $10M as on Dec 31, 2022

Employee Count

175 as on Aug 31, 2026

Similar Companies

Veritas Genetics & 107 more

Exit Details

Public

View GreenLight Biosciences' full profile

GreenLight Biosciences is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
GREENLIGHT BIOSCIENCES HOLDINGS, PBC CIN: 1822691 , United States, Active	Jul 01, 2020	$1M - $10M (As on Dec 31, 2022)	-	-
GREENLIGHT BIOSCIENCES INC CIN: 263322959 , United States, Active	Dec 31, 2008	-	144 (As on Dec 31, 2024)	-

GreenLight Biosciences got listed on Feb 03, 2022.

Click here to take a look at GreenLight Biosciences's IPO in detail

GreenLight Biosciences has raised a total funding of $225M over 13 rounds. Its first funding round was on Dec 21, 2009. Its latest funding round was a Post IPO round on Apr 07, 2025 for $25M. 1 investor participated in its latest round. GreenLight Biosciences has 38 institutional investors.

Here is the list of recent funding rounds of GreenLight Biosciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 07, 2025	$25M	Post IPO	-	-	-	Just Climate
Jul 01, 2024	$174K	Grant (prize money)	-	-	-	United States Department of Agriculture
Mar 01, 2024	$325K	Grant (prize money)	-	-	-	Europa

Access funding benchmarks and valuations. Sign up today!

View details of GreenLight Biosciences's funding rounds and investors

The founders of GreenLight Biosciences is Andrey Zarur. Andrey Zarur is the CEO of GreenLight Biosciences.

Here are the details of GreenLight Biosciences' key team members:

Andrey Zarur: Co-Founder & CEO of GreenLight Biosciences. They serve on the board of 1 company.

View details of GreenLight Biosciences's Founder profiles and Board Members

GreenLight Biosciences' employee count trend

GreenLight Biosciences has 175 employees as of Aug 26. Here is GreenLight Biosciences's employee count trend over the years:

Employee count trend for GreenLight Biosciences

Uncover GreenLight Biosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GreenLight Biosciences include Veritas Genetics, ARCpoint Labs and Dynacare. Here is the list of Top 10 competitors of GreenLight Biosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	GreenLight Biosciences 2008, Lexington (United States), Public	Developer of a platform for RNA-based products for life science industry	$225M	Trinity Capital, Kodiak Venture Partners ... & 36 others	66/100
2nd	Veritas Genetics 2014, Danvers (United States), Acquired	Provider of genetic testing products	$53.4M	Trustbridge Partners, Simcere Pharma & 6 others	55/100
3rd	ARCpoint Labs 2005, Greenville (United States), Public	Provider of genetic testing services	-	-	51/100
4th	Dynacare 1987, Brampton (Canada), Unfunded	Provider of diagnostics tests for the risk assessment needs of the life insurance industry	-	GTCR, Persistence Capital Partners	46/100
5th	Genotek 2010, Moscow (Russia), Seed	Direct-to-consumer genomic tests	$2.4M	MSU Business Incubator, Rustars Ventures & 1 others	43/100
6th	Kailos 2010, Huntsville (United States), Acquired	Provider of consumer-based genetic testing services	$3.9M	In-Q-Tel, New Capital Partners & 1 others	42/100
7th	Shanghai Yirui Biotechnology Co 2010, Jinshan (China), Series A	Developer of an online platform for genomics data analytics	$14.7M	Heda Capital, Chaosheng Capital & 1 others	41/100
8th	Face DNA Test 2018, London (United Kingdom), Unfunded	Provider of diversified DNA testing services	-	-	40/100
9th	Any Lab Test Now 1992, Alpharetta (United States), Unfunded	Provider of a portfolio of testing services	-	-	37/100
10th	Yunhu Technology Group 2017, Hangzhou (China), Series A	Provider of DNA testing services	$38.1M	Cash Capital, 5Y Capital & 5 others	37/100